Learn more

PRO NATURA GES FUER GESUNDE ER

Overview
  • Total Patents
    15
About

PRO NATURA GES FUER GESUNDE ER has a total of 15 patent applications. Its first patent ever was published in 2005. It filed its patents most often in Germany, WIPO (World Intellectual Property Organization) and United States. Its main competitors in its focus markets foods and drinks, pharmaceuticals and measurement are GLANBIA NUTRITIONALS IRELAND L, MISSBICHLER ALBERT and GOLINI JEFFREY M.

Patent filings in countries

World map showing PRO NATURA GES FUER GESUNDE ERs patent filings in countries

Patent filings per year

Chart showing PRO NATURA GES FUER GESUNDE ERs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Wyrobnik Isaac Harry 5
#2 Wyrobnik Daniel Henry 5
#3 Silcoff Elliad Ronen 2
#4 Wyrobnik Daniel 2
#5 Wyrobnik Harry 1

Latest patents

Publication Filing date Title
DE102007043056A1 Use of mannitol-dehydrogenase in medicine, for the therapy or diagnosis of disorder of fructose metabolism including fructose intolerance, to reduce bioavailability of fructose in human or animal and to produce e.g. food additive
DE102007026713A1 New 5-keto-D-fructose useful as medicaments, foodstuff e.g. marmalade, pasta, chocolate or sauces, sweetener, and for preparing products that are useful in the therapy of adiposity or diabetes
WO2007059956A1 Agent for use in the case of disorders of blood sugar metabolism, including diabetes
US2009214620A1 Agent for use in the case of disorders of blood sugar metabolism, including diabetes
DE102006014424A1 Use of glucose isomerase in combination with 5-D-fructose dehydrogenase and an enzyme, e.g. invertase, for producing a pharmaceutical composition for preventing, treating, or diagnosing diabetes
DE102006014420A1 New 5-D-fructose dehydrogenase in combination with an enzyme, e.g. glucose isomerase, useful for preventing or treating adiposity
DE102006013623A1 New 5-D-fructose-dehydrogenase useful e.g. as a medicament, food, dietetic food, food additives or a balanced diet and for the therapy of adiposity
DE102006012244A1 New 5-D-fructose dehydrogenase, optionally in combination with invertase, maltase and/or glucose isomerase, useful in therapy or diagnosis of disorders of fructose metabolism, including fructose intolerance
DE102006001017A1 Use of glucose isomerase in combination with 5-D-fructose dehydrogenase and an enzyme, e.g. invertase, for producing a pharmaceutical composition for preventing, treating, or diagnosing diabetes
DE102005061329A1 Use of glucose isomerase in combination with 5-D-fructose dehydrogenase and an enzyme, e.g. invertase, for producing a pharmaceutical composition for preventing, treating, or diagnosing diabetes
DE102005056103A1 Agent, useful to treat diabetes, comprises 5-D-fructose-dehydrogenase and glucose isomerase
DE102005049649A1 Composition, useful as e.g. nutritional supplement for the relief of gastro-intestinal tract complaints due to uptake of food containing oligosaccharide, comprises a combination of alpha-galactosidase and beta-fructofuraonosidase